Promising Results from Alzheimer’s Disease Passive Immunotherapy Support the Development of a Preventive Vaccine
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Promising Results from Alzheimer’s Disease Passive Immunotherapy Support the Development of a Preventive Vaccine
Authors
Keywords
-
Journal
Research
Volume 2019, Issue -, Pages 1-14
Publisher
American Association for the Advancement of Science (AAAS)
Online
2019-05-20
DOI
10.34133/2019/5341375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acylated and deacylated quillaja saponin-21 adjuvants have opposite roles when utilized for immunization of C57BL/6 mice model with MOG35-55 peptide
- (2019) Amir Reza Heidari et al. Multiple Sclerosis and Related Disorders
- Anti-Amyloid-β Monoclonal Antibodies for Alzheimer’s Disease: Pitfalls and Promise
- (2018) Christopher H. van Dyck BIOLOGICAL PSYCHIATRY
- Dendritic Cells as an Alternate Approach for Treatment of Neurodegenerative Disorders
- (2018) Veronika Brezovakova et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
- (2018) Erika N. Cline et al. JOURNAL OF ALZHEIMERS DISEASE
- Novel identified aluminum hydroxide-induced pathways prove monocyte activation and pro-inflammatory preparedness
- (2018) Sietske Kooijman et al. Journal of Proteomics
- Alzheimer's disease research: the future of BACE inhibitors
- (2018) Talha Burki LANCET
- Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants
- (2018) Dante J. Marciani TRENDS IN PHARMACOLOGICAL SCIENCES
- Molecular subtypes of Alzheimer’s disease
- (2018) Giuseppe Di Fede et al. Scientific Reports
- Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
- (2018) Judite R. M. Coimbra et al. Frontiers in Chemistry
- Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
- (2018) Alice Bittar et al. npj Vaccines
- Alzheimer’s Disease (AD) therapeutics - 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality
- (2018) Kevin Mullane et al. BIOCHEMICAL PHARMACOLOGY
- Promising Results in 18-Month Analysis of Alzheimer Drug Candidate
- (2018) Jennifer Abbasi JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Light at the End of the Amyloid Tunnel
- (2018) Dennis J. Selkoe BIOCHEMISTRY
- Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?
- (2018) Francesco Panza et al. Immunotherapy
- A Novel Crosslinking Protocol Stabilizes Amyloid β Oligomers Capable of Inducing Alzheimer's-Associated Pathologies
- (2018) Erika N. Cline et al. JOURNAL OF NEUROCHEMISTRY
- Active full-length DNA Aβ42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology
- (2018) Roger N. Rosenberg et al. Alzheimers Research & Therapy
- A mimotope of Aβ oligomers may also behave as a β-sheet inhibitor
- (2017) Yang-xin Zhang et al. FEBS LETTERS
- Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
- (2017) Yang Bai et al. Molecular Neurodegeneration
- A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer’s disease
- (2017) Shao-wei Wang et al. Alzheimers Research & Therapy
- CpG-ODN Shapes Alum Adjuvant Activity Signaling via MyD88 and IL-10
- (2017) Luciana Cristina Mirotti et al. Frontiers in Immunology
- Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go?
- (2017) Rommy von Bernhardi JOURNAL OF ALZHEIMERS DISEASE
- Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein
- (2016) Giusi Manassero et al. AGING CELL
- Alzheimer's disease research in Ibero America
- (2016) Heather M. Snyder et al. Alzheimers & Dementia
- Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies
- (2016) Bryan Briney et al. CELL
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- A retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies
- (2016) Dante J. Marciani JOURNAL OF NEUROCHEMISTRY
- ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
- (2016) Jinping Wang et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice
- (2016) Ksenia V. Kastanenka et al. JOURNAL OF NEUROSCIENCE
- Active Vaccines for Alzheimer Disease Treatment
- (2016) Rosalie M. Sterner et al. Journal of the American Medical Directors Association
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin
- (2016) Teng Wang et al. NEUROPHARMACOLOGY
- Mechanisms of Aβ Clearance and Degradation by Glial Cells
- (2016) Miriam Ries et al. Frontiers in Aging Neuroscience
- Prophylactic immunotherapy of Alzheimer's disease using recombinant amyloid-β B-cell epitope chimeric protein as subunit vaccine
- (2016) Yun-Zhou Yu et al. Human Vaccines & Immunotherapeutics
- The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
- (2016) Urmi Sengupta et al. EBioMedicine
- Alzheimer’s disease AdvaxCpG- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules
- (2016) Hayk Davtyan et al. Scientific Reports
- Developing therapeutic vaccines against Alzheimer’s disease
- (2015) Thomas Wisniewski et al. Expert Review of Vaccines
- Alzheimer's disease vaccine development: A new strategy focusing on immune modulation
- (2015) Dante J. Marciani JOURNAL OF NEUROIMMUNOLOGY
- An N-terminal antibody promotes the transformation of amyloid fibrils into oligomers and enhances the neurotoxicity of amyloid-beta: the dust-raising effect
- (2015) Yu-Hui Liu et al. Journal of Neuroinflammation
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
- (2015) Yu Tang et al. MOLECULAR NEUROBIOLOGY
- Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models
- (2015) Marc Aurel Busche et al. NATURE NEUROSCIENCE
- Clearance systems in the brain—implications for Alzheimer disease
- (2015) Jenna M. Tarasoff-Conway et al. Nature Reviews Neurology
- Amyloid Polymorphism: Structural Basis and Neurobiological Relevance
- (2015) Robert Tycko NEURON
- Advances in aluminum hydroxide-based adjuvant research and its mechanism
- (2015) Peng He et al. Human Vaccines & Immunotherapeutics
- New Th2 adjuvants for preventive and active immunotherapy of neurodegenerative proteinopathies
- (2014) Dante J. Marciani DRUG DISCOVERY TODAY
- Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKKε- and CYLD-dependent Bcl3 activation
- (2014) Sonja I. Gringhuis et al. Nature Communications
- Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics
- (2014) William F Goure et al. Alzheimers Research & Therapy
- Protein phosphorylation in neurodegeneration: friend or foe?
- (2014) Sandra Tenreiro et al. Frontiers in Molecular Neuroscience
- Pharmacology of BAN2401: A monoclonal antibody selective for beta-amyloid protofibrils
- (2013) Chad Swanson et al. Alzheimers & Dementia
- FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer’s disease
- (2013) Tae-In Kam et al. JOURNAL OF CLINICAL INVESTIGATION
- Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
- (2013) Richard Dodel et al. LANCET NEUROLOGY
- Naturally occurring autoantibodies interfere with β-amyloid metabolism and improve cognition in a transgenic mouse model of Alzheimer’s disease 24 h after single treatment
- (2013) D Mengel et al. Translational Psychiatry
- Properties of mouse and human IgG receptors and their contribution to disease models
- (2012) P. Bruhns BLOOD
- Efficacy of a Therapeutic Vaccine Using Mutated β-amyloid Sensitized Dendritic Cells in Alzheimer’s Mice
- (2012) Zhongqiu Luo et al. Journal of Neuroimmune Pharmacology
- Immunotherapy for Alzheimer disease—the challenge of adverse effects
- (2012) Yu-Hui Liu et al. Nature Reviews Neurology
- Large Aggregates Are the Major Soluble Aβ Species in AD Brain Fractionated with Density Gradient Ultracentrifugation
- (2012) Dag Sehlin et al. PLoS One
- Synergistic Interactions between Repeats in Tau Protein and Aβ Amyloids May Be Responsible for Accelerated Aggregation via Polymorphic States
- (2011) Yifat Miller et al. BIOCHEMISTRY
- Amyloid deposits: Protection against toxic protein species?
- (2011) Sebastian Treusch et al. CELL CYCLE
- CpG DNA as a vaccine adjuvant
- (2011) Christian Bode et al. Expert Review of Vaccines
- ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches
- (2011) Julien Delrieu et al. JOURNAL OF NEUROCHEMISTRY
- Soluble Aβ oligomer production and toxicity
- (2011) Megan E. Larson et al. JOURNAL OF NEUROCHEMISTRY
- Naturally Occurring Autoantibodies against -Amyloid: Investigating Their Role in Transgenic Animal and In Vitro Models of Alzheimer's Disease
- (2011) R. Dodel et al. JOURNAL OF NEUROSCIENCE
- Amyloid oligomers: formation and toxicity of Aβ oligomers
- (2010) Masafumi Sakono et al. FEBS Journal
- Anti-amyloidogenic Activity of IgGs Contained in Normal Plasma
- (2010) Brian O’Nuallain et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
- (2009) Bruno Vellas et al. Current Alzheimer Research
- Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease
- (2009) M. Britschgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
- (2008) Howard Jay Aizenstein et al. ARCHIVES OF NEUROLOGY
- Mutant Amyloid-beta-sensitized dendritic cells as Alzheimer's disease vaccine
- (2008) Chuanhai Cao et al. JOURNAL OF NEUROIMMUNOLOGY
- Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
- (2008) Raj N Kalaria et al. LANCET NEUROLOGY
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Vaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies
- (2003) Mary P. Lambert et al. JOURNAL OF NEUROCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search